Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma

Background:T lymphocyte infiltration has been detected in glioma, although its significance remains unclear. The purpose of the present study was to explore the prognostic value of CD4+ and CD8+ tumour-infiltrating lymphocytes (TILs) in glioma, and the prognostic value of infiltrating Forkhead box protein 3 (FoxP3+) regulatory T cells were also investigated.Methods:CD4+, FoxP3+ and CD8+ TILs were assessed by immunohistochemical staining of tissue microarray cores from 284 gliomas. Kaplan–Meier analysis and Cox proportional hazards models were used to examine the survival function of these TILs in 90 glioblastoma patients.Results:The number of CD8+ TILs was inversely correlated with tumour grade (P=0.025), whereas the number of CD4+ TILs was positively correlated with tumour grade (P=0.002). FoxP3+ TILs were only observed in glioblastomas, but not in low-grade astrocytomas or oligodendroglial tumours. Among patients with glioblastoma, none of CD4+ TILs, FoxP3+ TILs and CD8+ TILs alone was significantly associated with patient prognosis. However, the presence of high CD4+ and low CD8+ TIL levels was an independent predictor of poor progress-free survival (multivariate hazard ratio (HR) 1.618, 95% confidence interval (CI) 1.245–2.101, P<0.001) and poor overall survival (multivariate HR 1.508, 95% CI 1.162–1.956, P=0.002). Moreover, pseudoprogression was more often found in patients with high CD4+ TILs and high CD8+ TILs.Conclusions:The combination of CD4+ and CD8+ TILs is a predictor of clinical outcome in glioblastoma patients, and a high level of CD4+ TILs combined with low CD8+ TILs was associated with unfavourable prognosis.

• Publication year

  2014

• Venue

  British Journal of Cancer

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bjc.2014.162PMID 24691423PMCID 4021514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphorylated SATB1 is associated with the progression and prognosis of glioma

  2013cited by this paper
• The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma

  2013cited by this paper
• CD4⁺ follicular helper T cell infiltration predicts breast cancer survival.

  2013cited by this paper
• Tumour-infiltrating T-cell subpopulations in glioblastomas

  2012cited by this paper
• Functional differences between low- and high-affinity CD8+ T cells in the tumor environment

  2012cited by this paper
• Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression

  2011cited by this paper
• Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

  2011cited by this paper
• Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β

  2011cited by this paper
• CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes.

  2010cited by this paper
• Lymphocytes in cancer development: polarization towards pro-tumor immunity.

  2010cited by this paper
• Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

  2009cited by this paper
• In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

  2009cited by this paper
• Pseudoprogression and pseudoresponse in the treatment of gliomas

  2009cited by this paper
• MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.

  2008cited by this paper
• Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas

  2008cited by this paper
• Preferential In Situ CD4+CD56+ T Cell Activation and Expansion within Human Glioblastoma

  2008cited by this paper
• Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

  2007cited by this paper
• Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.

  2006cited by this paper
• An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.

  2006cited by this paper
• Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant Lesions

  2006cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

  2005influential reference
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005influential reference
• Intratumoral T Cell Subset Ratios and Fas Ligand Expression on Brain Tumor Endothelium

  2004cited by this paper
• The three Es of cancer immunoediting.

  2004cited by this paper
• Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium

  2003cited by this paper
• Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends.

  2002cited by this paper
• Cancer immunoediting: from immunosurveillance to tumor escape

  2002cited by this paper
• Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.

  1999cited by this paper
• Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset.

  1999cited by this paper
• Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies.

  1984cited by this paper
• Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases.

  1978cited by this paper
• Relationship of lymphocyte invasion and survival of brain tumor patients

  1978cited by this paper

• Proton radiotherapy offers immune-sparing benefits in glioblastoma treatment Proton therapy reduced radiation-induced lymphopenia.

  2026cites this paper
• Decoding the tumor immune landscape: emerging TIL subsets as prognostic biomarkers and therapeutic targets.

  2026cites this paper
• The immune awakening: Transformative strategies against brain tumors.

  2026cites this paper
• Characterization of the Systemic Effects of Casiopeina III‐Ia Using an In Vivo Glioma Model: Antitumoral, Pharmacokinetics, and Immune Responses

  2025cites this paper
• Intracranial injection of genetically modified, mosquito non-transmissible Zika virus: Safety in primates and ramifications for brain tumor therapy

  2025cites this paper
• Harnessing the role of insulin-like growth factor in glioblastoma: a comprehensive review.

  2025cites this paper
• The glioma microenvironment and its impact on antitumor immunity

  2025cites this paper
• Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression

  2025cites this paper
• Biological role and clinicopathological significance of leucine-rich α-2 glycoprotein 1 in the glioblastoma microenvironment.

  2025cites this paper
• Advancing vaccine-based immunotherapy in glioblastoma treatment

  2025cites this paper
• Emerging Neuroimmune Mechanisms in Cancer Neuroscience.

  2025cites this paper
• Mapping CD4+ T Cell Landscapes in Glioblastoma Reveals Effectors and Bystanders

  2025cites this paper
• Loss of B3GAT1/HNK-1 disrupts glioma-CD8+ T cell immune synapse formation for immune escape.

  2025cites this paper
• Unraveling Glioblastoma Heterogeneity: Advancing Immunological Insights and Therapeutic Innovations

  2025cites this paper
• Genomic landscape of diffuse glioma revealed by whole genome sequencing

  2025cites this paper
• Characterization of Tumor Immune Microenvironment in Meningiomas: Correlation of Tumor-infiltrating Lymphocyte Aggregates With Tumor Grade

  2025cites this paper
• Deciphering novel mitochondrial signatures: multi-omics analysis uncovers cross-disease markers and oligodendrocyte pathways in Alzheimer’s disease and glioblastoma

  2025cites this paper
• Tumor-infiltrating CD20+ B lymphocyte: evaluation and association with clinical and pathological characteristics in oral squamous cell carcinoma.

  2025cites this paper
• New insights on anti-tumor immunity of CD8+ T cells: cancer stem cells, tumor immune microenvironment and immunotherapy

  2025cites this paper
• Advancing glioblastoma immunotherapy: Molecular pathways and innovative therapeutic strategies.

  2025cites this paper
• Potential Biomarkers for IDH-Mutant and IDH-Wild-Type Glioblastomas: A Single-Center Retrospective Study

  2025cites this paper
• 5‐ALA Assisted Surgery of Human Glioblastoma Samples Reveals an Enrichment of T Cells Expressing PD‐1 and CD103 in the Intermediate and Marginal Layers

  2025cites this paper
• Immune-related lncRNAs signature and radiomics signature predict the prognosis and immune microenvironment of glioblastoma multiforme

  2024cites this paper
• Extracellular Matrix Structure and Interaction with Immune Cells in Adult Astrocytic Tumors

  2024cites this paper
• Gamma-aminobutyric acid-mediated neuro-immune interactions in glioblastoma: Implications for prognosis and immunotherapy response.

  2024cites this paper
• Dihydroartemisinin restores the immunogenicity and enhances the anticancer immunosurveillance of cisplatin by activating the PERK/eIF2α pathway

  2024cites this paper
• Detailed Profiling of the Tumor Microenvironment in Ethnic Breast Cancer, Using Tissue Microarrays and Multiplex Immunofluorescence

  2024cites this paper
• In Vitro Assessment of Thermo-Responsive Scaffold as a 3D Synthetic Matrix for CAR-T Potency Testing Against Glioblastoma Spheroids.

  2024cites this paper
• Polyinosinic/Polycytidylic Lipid Nanoparticles Enhance Immune Cell Infiltration and Improve Survival in the Glioblastoma Mouse Model

  2024cites this paper
• Ultrasound frequency-controlled microbubble dynamics in brain vessels regulate the enrichment of inflammatory pathways in the blood-brain barrier

  2024cites this paper
• Investigating the effects of protons versus x-rays on radiation-induced lymphopenia after brain irradiation

  2024cites this paper
• Flow cytometry detection and quantification of circulating leukocyte subpopulations in mice after brain irradiation.

  2024cites this paper
• Response assessment of GBM during immunotherapy by delayed contrast treatment response assessment maps

  2024cites this paper
• Systemic and local immunosuppression in glioblastoma and its prognostic significance

  2024cites this paper
• Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous

  2024cites this paper
• Necroptosis-based glioblastoma prognostic subtypes: implications for TME remodeling and therapy response

  2024cites this paper
• The biological behavior and clinical outcome of pituitary adenoma are affected by the microenvironment

  2024cites this paper
• Glioblastoma vaccines: past, present, and opportunities

  2024cites this paper
• Immunophenotypic Profile of Adult Glioblastoma IDH-Wildtype Microenvironment: A Cohort Study

  2024cites this paper
• Immune cell infiltration and inflammatory landscape in primary brain tumours

  2024cites this paper
• Tumor cell–derived spermidine promotes a protumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition

  2024cites this paper
• Single-cell spatial mapping reveals alteration of tissue microenvironment during early colorectal cancer

  2024cites this paper
• Potential Guiding Significance of NRF2 in Immunotherapy for Gastric Cancer

  2024cites this paper
• Current mRNA-Based Vaccine Strategies for Glioma Treatment.

  2024cites this paper
• Role of T Lymphocytes in Glioma Immune Microenvironment: Two Sides of a Coin

  2024cites this paper
• Evaluation of Neutrophil Lymphocyte Ratio and IDH Mutation in Patients with Glioblastoma

  2023cites this paper
• Single-Cell RNA Sequencing Pro-angiogenic Macrophage Profiles Reveal Novel Prognostic Biomarkers and Therapeutic Targets for Osteosarcoma

  2023cites this paper
• MYEF2: an immune infiltration-related prognostic factor in IDH-wild-type glioblastoma

  2023cites this paper
• EGFR alterations in glioblastoma play a role in antitumor immunity regulation

  2023cites this paper
• Current landscape and challenges ahead of immuno-molecular mechanism and immunotherapy strategy of brain metastases

  2023cites this paper
• Deciphering immune microenvironment and cell evasion mechanisms in human gliomas

  2023cites this paper
• Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma

  2023cites this paper
• Radiomics for characterization of the glioma immune microenvironment

  2023cites this paper
• TMIGD2 as a potential therapeutic target in glioma patients

  2023cites this paper
• BCAT1 regulates glioblastoma cell plasticity and contributes to immunosuppression

  2023cites this paper
• The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma.

  2023cites this paper
• PD-L1 and tumor-infiltrating CD8+ lymphocytes are correlated with clinical characteristics in pediatric and adolescent pituitary adenomas

  2023cites this paper
• The efficacy and safety of anti-PD-1/PD-L1 in treatment of glioma: a single-arm meta-analysis

  2023influential citation
• Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma model.

  2023cites this paper
• The need of radiotherapy optimization for glioblastomas considering immune responses

  2023cites this paper
• Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma

  2023influential citation
• Pre-therapeutic lymphocytopenia: a new prognostic factor for failure of endovesical BCG-immunotherapy in non-muscle invasive bladder cancer

  2023cites this paper
• Prognostic role of the pretreatment systemic immune-inflammation index in patients with glioma: A meta-analysis

  2023cites this paper
• Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?

  2023cites this paper
• Development of a human glioblastoma model using humanized DRAG mice for immunotherapy

  2023cites this paper
• Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas

  2023cites this paper
• High expression of ARPC1B correlates with immune infiltration and poor outcomes in glioblastoma

  2023cites this paper
• Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models

  2023cites this paper
• Brain regulatory T cells

  2023cites this paper
• Vasari-Based Features Nomogram to Predict the Tumor-Infiltrating CD8+ T Cell Levels in Glioblastoma.

  2023cites this paper
• Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differences

  2023cites this paper
• Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth

  2023cites this paper
• PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers

  2023cites this paper
• Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions

  2023cites this paper
• Development of a human glioblastoma model using humanized DRAG mice for immunotherapy

  2023cites this paper
• The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw

  2023influential citation
• MRI histogram analysis of tumor-infiltrating CD8+ T cell levels in patients with glioblastoma

  2023cites this paper
• Bioactive compounds from Actinidia arguta fruit as a new strategy to fight glioblastoma.

  2023cites this paper
• Association of RNA-modification “writer” genes with prognosis and response to immunotherapy in patients with low-grade glioma

  2023cites this paper
• Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape

  2023cites this paper
• Tumor cell-derived spermidine promotes a pro-tumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition

  2023cites this paper
• Synergistic immunostimulation for tumor sensitization with a biomineralized DNA sponge

  2023cites this paper
• BCAT1 regulates glioblastoma cell plasticity and contributes to immunosuppression.

  2023cites this paper
• Multimodal deep learning to predict prognosis in adult and pediatric brain tumors

  2023cites this paper
• BZW1 as an oncogene is associated with patient prognosis and the immune microenvironment in glioma.

  2023cites this paper
• The strange Microenvironment of Glioblastoma.

  2023cites this paper
• PD-L1-related IncRNAs are associated with malignant characteristics and immune microenvironment in glioma

  2023cites this paper
• Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies

  2023cites this paper
• Engineering MMP-2 Activated Nanoparticles Carrying B7-H3 Bispecific Antibodies for Ferroptosis-Enhanced Glioblastoma Immunotherapy.

  2023cites this paper
• Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma.

  2023cites this paper
• The co-inhibitory immune checkpoint proteins B7-H1(PD-L1) and B7-H4 in high grade glioma: From bench to bedside

  2023cites this paper
• Ventricular opening and cerebrospinal fluid circulation accelerate the biodegradation process of carmustine wafers suggesting their immunomodulation potential in the human brain

  2022cites this paper
• Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers

  2022cites this paper
• Hedgehog signaling regulates the development and treatment of glioblastoma

  2022cites this paper
• Immune surveillance in glioblastoma: Role of the NKG2D system and novel cell‐based therapeutic approaches

  2022cites this paper
• Comparison of tumor immune environment between newly diagnosed and recurrent glioblastoma including matched patients

  2022cites this paper
• The Pathological Evaluation of Autophagy-Related Protein (LC3B) and Its Association with the Infiltration of Immune Cells in Glioma

  2022cites this paper
• gp96 Expression in Gliomas and Its Association with Tumor Malignancy and T Cell Infiltrating Level

  2022cites this paper
• GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma

  2022cites this paper
• Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas

  2022cites this paper